2022
Correlation between reflux time and venous clinical severity score in patients undergoing saphenous vein ablation: A prospective study
Kokkinidis D, Chaar C, Mena-Hurtado C, Attaran R. Correlation between reflux time and venous clinical severity score in patients undergoing saphenous vein ablation: A prospective study. Phlebology The Journal Of Venous Disease 2022, 38: 62-66. PMID: 36524895, DOI: 10.1177/02683555221146730.Peer-Reviewed Original ResearchConceptsVenous Clinical Severity ScoreClinical severity scoreSaphenous vein ablationVein refluxVein ablationProspective studySeverity scoreGreat saphenous vein refluxGreat saphenous vein ablationReflux timeMean reflux timesSuperficial vein refluxDeep vein refluxSaphenous vein refluxAnalysis of patientsTime of ablationSeverity of symptomsUnderwent ablationSymptomatic refluxPatientsSpearman rank correlationRefluxAblationPoor correlationScores
2021
Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry
Scierka LE, Jelani QU, Smolderen KG, Gosch K, Spertus JA, Mena-Hurtado C, Jones P, Dreyer RP. Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry. Contemporary Clinical Trials 2021, 112: 106624. PMID: 34793986, DOI: 10.1016/j.cct.2021.106624.Peer-Reviewed Original ResearchConceptsOptimal medical therapyPeripheral artery diseasePatient characteristicsBaseline patient characteristicsPAD cohortPAD populationPORTRAIT registryExercise therapyPAD patientsPAD symptomsArtery diseaseFinal cohortMedical therapyProspective studyBurdensome diseaseControl trialHealth statusPatientsTherapyCohortCLEVER studyDiseaseMulticenterRevascularizationRCTsCorrelation between great saphenous length of treatment zone and diameter with improvement in symptoms after ablation
Attaran RR, Bhalla A, Mena-Hurtado CI, Ochoa Chaar CI. Correlation between great saphenous length of treatment zone and diameter with improvement in symptoms after ablation. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2021, 9: 1443-1450. PMID: 33706000, DOI: 10.1016/j.jvsv.2021.02.013.Peer-Reviewed Original ResearchConceptsVenous Clinical Severity ScoreGSV diameterCyanoacrylate closureRadiofrequency ablationSymptom improvementGSV segmentsGroup IIGroup IMedian treatment lengthClinical severity scoreSignificant differencesGSV refluxReflux scorePoor correlationProspective studySeverity scoreStudy populationTreatment lengthGreater severityPatientsSymptom severityPooled dataLong segmentTime pointsBaseline
2020
Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient‐level pooled data analysis
Madhavan MV, Shahim B, Mena‐Hurtado C, Garcia L, Crowley A, Parikh SA. Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient‐level pooled data analysis. Catheterization And Cardiovascular Interventions 2020, 95: 959-968. PMID: 31957955, PMCID: PMC7187419, DOI: 10.1002/ccd.28729.Peer-Reviewed Original ResearchConceptsIndividual patient-level dataPeripheral arterial diseaseUse of IVLIntravascular lithotripsyArterial diseaseProspective studyTreatment of PADSafety of IVLPeripheral arterial calcificationPeripheral artery calcificationPeripheral intravascular lithotripsyProcedural angiographic complicationsFlow-limiting dissectionIndependent core laboratoryTreatment of patientsPercent diameter stenosisLong-term patencyPatient-level dataAngiographic complicationsAcute successEfficacy endpointEndovascular revascularizationSafety endpointArtery calcificationDistal embolization
2013
The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy.
Meller SM, Stilp E, Walker CN, Mena-Hurtado C. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. Journal Of Invasive Cardiology 2013, 25: 313-9. PMID: 23735361.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseCoronary artery diseaseVasculogenic erectile dysfunctionErectile dysfunctionArtery diseaseEndovascular therapyMetabolic factorsPathophysiology of EDArtery size hypothesisIncident clinical eventsPelvic arterial anatomyLarge prospective studiesCommon risk factorsQuality of lifeDiagnostic imaging modalitiesMacrovascular diseasePercutaneous revascularizationEndothelial dysfunctionDiabetes mellitusPathophysiological linkProspective studyArterial anatomyClinical eventsCurrent therapiesRisk factors